Abstract
In addition to their traditional role as a source of natural medicines, it is now possible to genetically engineer plants to produce pharmaceuticals. Transgenic plants expressing antigens from pathogenic microorganisms offer many advantages as low-cost production systems and effective delivery systems for vaccines. This new technology might contribute to global vaccine programs and might have a dramatic impact on health care in developing countries.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Review
MeSH terms
-
Administration, Oral
-
Animals
-
Antigens, Bacterial / genetics
-
Antigens, Bacterial / immunology
-
Antigens, Viral / genetics
-
Antigens, Viral / immunology
-
Bacterial Vaccines / genetics
-
Bacterial Vaccines / immunology*
-
Humans
-
Plants, Genetically Modified* / immunology
-
Vaccines, DNA / immunology*
-
Viral Vaccines / genetics
-
Viral Vaccines / immunology*
Substances
-
Antigens, Bacterial
-
Antigens, Viral
-
Bacterial Vaccines
-
Vaccines, DNA
-
Viral Vaccines